TITLE

BENULOSE--A NEW ADJUNCT IN THE TREATMENT OF FUNCTIONAL BOWEL DISTRESS

AUTHOR(S)
Cane, Walter
PUB. DATE
November 1959
SOURCE
American Journal of Gastroenterology;Nov1959, Vol. 32 Issue 5, p649
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the study "Benulose--A New Adjunct in the Treatment of Functional Bowel Distress," by Charles W. Hock.
ACCESSION #
16444678

 

Related Articles

  • Models of disease under constant review.  // New Zealand Doctor;12/15/2004, p22 

    Presents information on symptoms of functional bowel diseases. Important factors in the models of functional bowel diseases; Factor that resembles the response of normal individuals to stress; Experimental observations to irritable bowel movement.

  • Audit of Constipation in a Gastroenterology Referral Center. Guido Iantorno; Monica Cinquetti; Alessandro Mazzocchi; Antonio Morelli; Gabrio Bassotti // Digestive Diseases & Sciences;Feb2007, Vol. 52 Issue 2, p317 

    Abstract??This study was designed to assess the various subtypes of functional constipation in a referral gastrointestinal center of a Latino-American country. All patients referred for evaluation of constipation during a 10-year period were audited, and those with functional constipation...

  • Rectal irrigation for relief of functional bowel disorders. Gardiner, Angela; Marshall, Jill; Duthie, Graeme // Nursing Standard;11/10/2004, Vol. 19 Issue 9, p39 

    This article examines the use of rectal irrigation for the symptomatic relief of functional bowel disorders in certain groups of patients. The authors undertook a study of 80 patients and conclude that it is a valuable treatment for some patients.

  • Epidemiology of Functional Diarrhea and Comparison with Diarrhea- Predominant Irritable Bowel Syndrome: A Population-Based Survey in China. Yan-Fang Zhao; Xiao-Jing Guo; Zhan-Sai Zhang; Xiu-Qiang Ma; Rui Wang; Xiao-Yan Yan; Jia He; Kirk, Martyn // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Background: The epidemiology of functional diarrhea and its impacts on Chinese remain unclear, and there are no data on the comparative epidemiology of functional diarrhea and diarrhea-predominant irritable bowel syndrome (IBS-D). This study was to explore the epidemiology of functional...

  • Irritable Bowel Syndrome: Controlling Your Symptoms.  // American Family Physician;12/15/2010, Vol. 82 Issue 12, Special section p1 

    The article provides information on irritable bowel syndrome (IBS). Also known as functional bowel syndrome or irritable colon, IBS refers to an intestinal disorder which commonly starts around age 20 and is more frequent among women. Among the symptoms of IBS include bloating and gas, mucus in...

  • The Irritable Bowel Syndrome. Horwitz, Brenda J.; Fisher, Robert S. // New England Journal of Medicine;06/14/2001, Vol. 344 Issue 24, p1846 

    Presents information on irritable bowel syndrome. Epidemiologic features, including altered bowel motility; Diagnosis; Treatment; Value of establishment of trust in doctor-patient relationship.

  • Positive diagnosis of IBS can be made.  // New Zealand Doctor;12/15/2004, p24 

    Presents information on a diagnosis of irritable bowel movement. Final change in nomenclature of the term irritable bowel syndrome (IBS); Reason for the wide influence of the Manning criteria, which was derived from a research paper by Manning and his colleagues on IBS; Factors that determine...

  • Alosetron Controls Bowel Urgency and Provides Global Symptom Improvement in Women With Diarrhea-Predominant Irritable Bowel Syndrome. Lembo, Tony; Wright, Richard A.; Bagby, Barbara; Decker, Chris; Gordon, Susan; Jhingran, Priti; Carter, Eric // American Journal of Gastroenterology;Sep2001, Vol. 96 Issue 9, p2662 

    OBJECTIVES: Bowel urgency is one of the most bothersome symptoms for nonconstipated IBS patients. The efficacy of alosetron in control of bowel urgency and Global Improvement of IBS symptoms were evaluated in a multicenter double-blind, randomized, placebo-controlled study. METHODS: Female IBS...

  • Gender-Related Differences in Slowing Colonic Transit By a 5-HT3 Antagonist in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome. Viramontes, Blanca E.; Camilleri, Michael; McKinzie, Sanna; Pardi, Darrell S.; Burton, Duane; Thomforde, George M. // American Journal of Gastroenterology;Sep2001, Vol. 96 Issue 9, p2671 

    OBJECTIVE: To evaluate the influence of gender on the effect of a 5-HT3 antagonist, alosetron, 1 mg b.i.d., on GI and colonic transit in D-IBS. METHODS: Thirty patients (15 male. 15 female) with D-IBS received 1 mg b.i.d. alosetron for 6 wk. Transit was measured by scintigraphy...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics